Related Experiment Video

Updated: Aug 29, 2026

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

SRC in human carcinogenesis

Salvatore V Russello1, Scott K Shore

  • 1Fels Institute for Cancer Research and Department of Biochemistry, Temple University School of Medicine, 3307 N. Broad Street, Philadelphia, PA 19140, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|February 10, 2004
PubMed

Insights

The non-receptor tyrosine kinase Src plays a critical role in cell signaling and cancer. Aberrant Src activity or expression in tumors like colon and breast cancer is linked to disease progression and metastasis.

Area of Science:

  • Cellular signaling and molecular biology
  • Oncology and cancer research
  • Biochemistry and protein function

Background:

  • Cell signaling relies on complex protein networks for communication.
  • Non-receptor tyrosine kinases, such as Src, are key intermediaries in cellular pathways.
  • While viral Src is carcinogenic, its role in human tumors requires further characterization.

Purpose of the Study:

  • To investigate the role of the non-receptor tyrosine kinase Src in neoplasia.
  • To determine if Src activity or expression impacts cancer prognosis and pathogenicity.
  • To examine Src's involvement in common human tumors.

Main Methods:

  • Analysis of Src protein expression and activity in tumor samples.
  • Correlation studies linking Src status to clinical parameters.
  • Investigation of Src's role in cell growth, migration, and genome maintenance pathways.

Main Results:

  • Src non-receptor tyrosine kinase is overexpressed or constitutively active in a significant proportion of colon and breast tumors.
  • Elevated Src expression or activity correlates with advanced tumor stage.
  • Increased Src activity is associated with higher metastatic potential in certain cancers.

Conclusions:

  • Perturbations in Src activity or expression are significant factors in cancer pathogenicity.
  • Src is a potential biomarker for clinical prognosis in various neoplasias.
  • Targeting Src may offer therapeutic strategies for managing cancer progression and metastasis.

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...